Subject(s)
Antiviral Agents/therapeutic use , Heart Failure/drug therapy , Heart Transplantation/methods , Hepatitis C, Chronic/drug therapy , Therapies, Investigational/methods , Tissue Donors/supply & distribution , Heart Failure/surgery , Heart Transplantation/trends , Humans , Therapies, Investigational/trendsABSTRACT
This document was developed through the collaborative efforts of the Society of Critical Care Medicine, the American College of Chest Physicians, and the Association of Organ Procurement Organizations. Under the auspices of these societies, a multidisciplinary, multi-institutional task force was convened, incorporating expertise in critical care medicine, organ donor management, and transplantation. Members of the task force were divided into 13 subcommittees, each focused on one of the following general or organ-specific areas: death determination using neurologic criteria, donation after circulatory death determination, authorization process, general contraindications to donation, hemodynamic management, endocrine dysfunction and hormone replacement therapy, pediatric donor management, cardiac donation, lung donation, liver donation, kidney donation, small bowel donation, and pancreas donation. Subcommittees were charged with generating a series of management-related questions related to their topic. For each question, subcommittees provided a summary of relevant literature and specific recommendations. The specific recommendations were approved by all members of the task force and then assembled into a complete document. Because the available literature was overwhelmingly comprised of observational studies and case series, representing low-quality evidence, a decision was made that the document would assume the form of a consensus statement rather than a formally graded guideline. The goal of this document is to provide critical care practitioners with essential information and practical recommendations related to management of the potential organ donor, based on the available literature and expert consensus.
Subject(s)
Intensive Care Units/organization & administration , Practice Guidelines as Topic , Tissue Donors , Tissue and Organ Procurement/organization & administration , Death , Humans , Intensive Care Units/standards , Patient Rights , Societies, Medical , Tissue and Organ Procurement/standards , United StatesABSTRACT
Despite the growing disparity between organ supply and demand in the United States, few initiatives have attempted to close the gap through systematic population-based public health endeavors. We examined the evolution, implementation, and outcomes of the Massachusetts Organ Donation Initiative, a statewide effort that included a unique partnership among organ procurement organizations, major teaching hospitals, and the state's department of public health. Lessons from this initiative have contributed to growing national efforts for increasing organ supply and have provided insights for addressing this continuing public health challenge.
Subject(s)
Hospitals, Teaching/organization & administration , Interinstitutional Relations , Organizations, Nonprofit/organization & administration , Public Health Administration , Tissue and Organ Procurement/organization & administration , Cooperative Behavior , Eligibility Determination , Humans , Leadership , Massachusetts , Organizational Case Studies , Organizational Innovation , Program Development , Program Evaluation , Tissue Donors/statistics & numerical data , Total Quality Management , Transplants/statistics & numerical data , Waiting ListsSubject(s)
Critical Care/methods , Critical Illness/nursing , Organ Transplantation/statistics & numerical data , Tissue and Organ Procurement/methods , Brain Death , Clinical Protocols , Female , Graft Rejection/prevention & control , Graft Survival , Humans , Informed Consent , Living Donors/supply & distribution , Male , Referral and Consultation/statistics & numerical data , Sensitivity and Specificity , Tissue Donors/supply & distributionABSTRACT
The development of efficient and inexpensive genome sequencing methods has revolutionized the study of human bacterial pathogens and improved vaccine design. Unfortunately, the sequence of a single genome does not reflect how genetic variability drives pathogenesis within a bacterial species and also limits genome-wide screens for vaccine candidates or for antimicrobial targets. We have generated the genomic sequence of six strains representing the five major disease-causing serotypes of Streptococcus agalactiae, the main cause of neonatal infection in humans. Analysis of these genomes and those available in databases showed that the S. agalactiae species can be described by a pan-genome consisting of a core genome shared by all isolates, accounting for approximately 80% of any single genome, plus a dispensable genome consisting of partially shared and strain-specific genes. Mathematical extrapolation of the data suggests that the gene reservoir available for inclusion in the S. agalactiae pan-genome is vast and that unique genes will continue to be identified even after sequencing hundreds of genomes.
Subject(s)
Genome, Bacterial , Streptococcus agalactiae/classification , Streptococcus agalactiae/genetics , Amino Acid Sequence , Bacterial Capsules/genetics , Base Sequence , Gene Expression , Genes, Bacterial , Genetic Variation , Molecular Sequence Data , Phylogeny , Sequence Alignment , Sequence Analysis, DNA , Streptococcus agalactiae/pathogenicity , Virulence/geneticsABSTRACT
Kidney transplantation confers a survival advantage for patients with end-stage renal disease (ESRD) when compared to dialysis and improves the quality of life in a cost-effective manner. Currently there are more than 60,000 patients on the U.S. waiting list for kidney transplantation. In 2004, 16,879 kidney transplants, including 880 simultaneous kidney and pancreas transplants, were performed in this country. Recent strategies for increasing the supply of kidneys hold promise, such as systematic programs designed to improve consent rates for deceased donor organ procurement. Efforts to increase donation after cardiac death (DCD) have been highly successful and now account for more than 5% of all deceased organ donors. Transplantation of kidneys from DCD donors yields 1-year graft and patient survival rates equivalent to kidneys from brain-dead donors. Expanded criteria donor (ECD) kidneys from donors > or = 60 years of age (or donors age 50-59 years with certain comorbidities) confer a survival benefit for end-stage renal disease (ESRD) patients compared to remaining on dialysis on the waiting list. The number of live donor kidney transplants, both from biologically related and unrelated donors, is increasing. Paired live donor kidney transplants provide yet another transplantation opportunity for ESRD patients with willing but incompatible (by ABO or direct antibody) living donors.
Subject(s)
Kidney Failure, Chronic/epidemiology , Kidney Failure, Chronic/surgery , Kidney Transplantation/statistics & numerical data , Tissue and Organ Procurement/methods , Cadaver , Humans , Living Donors/statistics & numerical data , Pancreas Transplantation/statistics & numerical data , United States/epidemiology , Waiting ListsABSTRACT
Many people die owing to the shortage of donor organs. Medical examiners and coroners (MEs/Cs) play a vital role in making organs available for potential recipients. Medical examiners'/coroners' case data were collected using a structured confirmatory-recorded methodology for calendar years 2000-01 and were linked and analyzed with donor and transplant data from the United Network for Organ Sharing, predicting the nature and extent of the loss of donor organs. Nearly seven percent of ME/C cases were denied recovery during 2000-01. Because 353 and likely, 411 potential organ donors (PODs) were denied, as many as 1400 persons on transplant waiting lists did not receive organs because of ME/C denials. Problematically for pediatric patients awaiting transplantation, nearly half of all ME/C denials occurred in pediatric patients. Eighteen percent of PODs aged five or less and 44.2% of child abuse PODs were denied recovery by the ME/C. There were no (zero) denials in three of the five largest U.S. cities and in four states. Since 1994, two states have enacted legislation restricting the circumstances of ME/C denials, resulting in an 83% decrease in ME/C denials. Release of all organs from ME/C cases is needed urgently to protect the lives of those persons awaiting transplantation. Medical examiners and coroners deserve recognition for their efforts in advocating methods and/or regulation/legislation designed to achieve 100% release of life-saving organs for transplantation.
Subject(s)
Coroners and Medical Examiners , Tissue Donors/supply & distribution , Cadaver , Humans , Patient Selection , Tissue and Organ Procurement/organization & administration , United StatesSubject(s)
Hepatitis, Viral, Human/etiology , Hepatitis, Viral, Human/transmission , Neoplasms/etiology , Organ Transplantation/adverse effects , Hepatitis, Viral, Human/epidemiology , Humans , Neoplasms/epidemiology , Organ Transplantation/statistics & numerical data , Risk Factors , Tissue Donors/statistics & numerical dataABSTRACT
Viewers were presented with a rapid sequence of very brief stimulus pairs, each of which consisted of a pictured object followed by a related or unrelated word. The form of relatedness between the picture and word was manipulated across experiments (identical concept, associated concept, ink color of the picture). Recognition memory for the pictures was affected not only by whether or not paired items were conceptually identical or semantically related, but also by whether or not the words named an irrelevant feature, ink color. These results show that sequential items are integrated on the basis of similarity at whatever level is available, so that the stability of the memory representation of one or both items is increased. We propose that a common mechanism may underlie integration, priming, and selective attention.